The lateral periaqueductal gray (lPAG) is a midbrain region that plays crucial roles in pain modulation, fear responses, and autonomic control. This region is part of the descending pain modulatory system and is implicated in neurodegenerative conditions involving pain processing and emotional regulation.
Lateral Periaqueductal Gray (lPAG) neurons are located in the midbrain aqueduct's lateral walls. The PAG is organized in columns, with the lateral column being particularly important for:
- Pain modulation and analgesia
- Fear and anxiety responses
- Cardiovascular regulation
- Vocalization
Key characteristics:
- Part of descending pain modulatory system
- Receives input from spinal cord pain neurons
- Projects to brainstem and spinal cord
- Contains both excitatory and inhibitory neurons
¶ Morphology and Markers
- Cell Type: Mixed population (glutamatergic, GABAergic, serotonergic)
- Marker Genes: VGlut2 (Slc17a6), GAD1/2, Tph2 (serotonergic subset)
- Neurotransmitter: Glutamate, GABA, Serotonin
- Morphology: Medium-sized neurons with extensive dendritic fields
- Location: Midbrain, surrounding the cerebral aqueduct
The lPAG is a key hub in endogenous pain control:
- Descending Inhibition: Activates dorsal horn inhibitory interneurons
- Opioid-mediated analgesia: Target of morphine and other analgesics
- Stimulation-produced analgesia: Electrical stimulation induces pain relief
¶ Fear and Anxiety
- Fear conditioning: lPAG activation during aversive learning
- Freezing behavior: Mediates fear-induced immobility
- Anxiety circuits: Interactions with amygdala and prefrontal cortex
- Cardiovascular responses: Blood pressure and heart rate modulation
- Respiratory effects: Modulates breathing patterns
- Stress responses: Activates hypothalamic-pituitary-adrenal axis
- Pain processing deficits: Altered pain perception in AD
- Anatomical involvement: PAG receives amyloid pathology
- Autonomic dysfunction: Contributes to autonomic symptoms
- Pain abnormalities: PD patients experience various pain syndromes
- Freezing of gait: lPAG involvement in postural control
- Autonomic failure: Contributes to orthostatic hypotension
- Pain involvement: Both nociceptive and neuropathic pain
- Respiratory PAG control: May affect breathing regulation
- Emotional processing: Changes in emotional responses
- Deep brain stimulation: lPAG DBS for refractory pain
- Transcranial magnetic stimulation: Targeting PAG for analgesia
- Pharmacological: Opioid and non-opioid pain medications
- PAG stimulation: Used for chronic pain treatment
- Neurofeedback: Biofeedback for pain regulation
- Pharmacological targets: 5-HT1A, opioid receptors
- Electrophysiology: In vivo and in vitro recordings
- Optogenetics: Channelrhodopsin/Chlamyodopsin manipulation
- Fos expression: Activity mapping
- Tracing: Anterograde and retrograde tract tracing
The study of Lateral Periaqueductal Gray (Lpag) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Bandler et al., Periaqueductal gray (2000)
- Behbehani, Functional characteristics of PAG (1995)
- Millan, Pain control and PAG (2002)
- Saaber et al., Pain in Parkinson's disease (2018)